%20(5%20%C3%97%203%20cm)%20(4%20%C3%97%202%20cm).jpg)
A better quality of life
through protection and activation of mitochondria
​​
Scientific rationale and historical background
​
The conceptual foundations of mitochondrial medicine emerged in the late 1960s within pioneering research on neuromuscular and metabolic disorders, including Duchenne muscular dystrophy. Early work by Karl Folkers on Coenzyme Q10 deficiency and mitochondrial dysfunction provided key insights into the role of impaired cellular energy metabolism in chronic disease
​
​This scientific environment also shaped the later work of Dr. Enzmann,
who collaborated with Karl Folkers and contributed to the development of the mitochondrial concepts applied today.
​
Dr Franz Enzmann has developed the MitoMed concept
-
based on diagnosis and functional assessment rather than generic wellness or symptom-driven approaches.
-
supported by structured medical education programs, including regular professional trainings offered up to five times per year.
​​
Mitochondria as the functional basis
-
Many of the targeted indication areas (intestinal barrier integrity, immune response, hepatic metabolism, stress adaptation, neuromuscular function) are highly energy-dependent.
-
At the cellular level, these functions are critically dependent on mitochondrial performance.
-
Coenzyme Q10 occupies a central functional position, acting as the essential electron carrier between complexes I/II and III and thereby directly determining ATP generation, redox stability, signaling pathways, membrane integrity, respiratory chain efficiency.
​​
Mitochondria medicine represents a complementary, deeper functional strategy, especially relevant when:
-
standard approaches show limited efficacy
-
symptoms are multifactorial
-
chronic energy or regulatory deficits are present
